代謝および心血管疾患におけるGDF15の新たな役割

Tian Tian^1,2, Monan Liu^1,2, Peter J Little³

¹Department of Endocrinology, Centre for Leading Medicine and Advanced Technologies of IHM, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.

Research (Washington, D.C.)

|August 21, 2025

まとめ

成長差別化因子15 (GDF15) は,代謝と炎症における重要なサイトカインである. このレビューは,GDF15の詳細を示しています.

科学分野:

内分泌学と代謝
分子生物学
セルラー・シグナル

背景:

成長差別化因子15 (GDF15) は,TGF-βスーパーファミリーのストレス反応性サイトカインである.
それは代謝と炎症の調節に重要な役割を果たします.
GFRALは,GDF15の効果を媒介する中央受容体として特定されています.

研究の目的:

GDF15の発現,調節,および機能の包括的なレビューを提供するために.
GDF15を様々な代謝疾患と老化に結びつける証拠を集約する
現在のGDF15標的薬の開発を評価し,将来の研究方向を特定する.

主な方法:

GDFに関する既存の研究の文献レビューと要約15.
制御ネットワークと他の代謝因子の相互作用の分析
GDFの治療戦略と薬物開発の評価15.

主要な成果:

GDF15の発現は複雑な規制ネットワーク (例えば,ATF4/CHOP,AMPK,p53) によって制御され,ライフスタイルの介入によって調節されます.
GDF15は肥満,糖尿病,心血管疾患,代謝性肝臓障害,カシェキア,サルコペニア,そして老化に関連しています.
GDF15の発現を誘導する薬剤や天然化合物は様々なものです.

結論:

GDF15は全代謝健康における重要な媒介であり,心臓代謝疾患における重要な治療的可能性を持っています.
GDF15を標的とした薬の開発の進展は,単一クローン抗体,融合タンパク質,および小分子を含む有望な結果を示しています.
周辺受容体や治療開発における課題を含む未解決の問題に対処するためにさらなる研究が必要である.

さらに関連する動画

06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

764

05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

287

関連する概念動画

01:27

Regulation of the Cardiovascular System

1.8K

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

1.8K

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:19

Regulation of Metabolism

9.9K

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...

9.9K

01:20

Pathophysiology of Diabetes

1.2K

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

1.2K

01:28

Role of Hematopoietic Growth Factors

1.7K

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...

1.7K

01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...